Ad Header



The Pulse of the Pharmaceutical Industry

Roche’s MabTherea shot gets EU OK for chronic lymphocytic leukemia

Written by: | | Dated: Tuesday, May 31st, 2016


The European Commission approved the injection for people with previously untreated and relapsed/refractory forms of the disease.

“MabThera SC provides patients with significantly faster treatment administration and the opportunity to enjoy more time outside the clinical setting compared to intravenous delivery of the medicine,” Chief Medical Officer Sandra Horning said.


(Reporting by Brenna Hughes Neghaiwi; Editing by Michael Shields)

Source: Reuters Health

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

February 2018 Focus: Top 10 Pipelines, Focused Value in Pharma, Agenda 2018 and MAHF!


Ad Right Bottom

Main Navigation